Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase

Journal of Lipid Research

Volumn 54, Issue 7, 2013, Pages 1834-1847

  Mietla, Jennifer A ^a   Wijesinghe, Dayanjan S ^a,b   Hoeferlin, L Alexis ^a   Shultz, Michael D ^a,b   Natarajan, Ramesh ^a   Fowler III, Alpha A ^a   Chalfant, Charles E ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Ceramide 1 phosphate; Cytosolic phospholipase A2; Eicosanoids; Inflammation

Indexed keywords

11 HYDROXYICOSATETRAENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; 8 HYDROXYARACHIDONIC ACID; ARACHIDONIC ACID; CALCIMYCIN; CERAMIDE 1 PHOSPHATE; CERAMIDE KINASE; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE E4; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CERK GENE; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; EX VIVO STUDY; GENE; GENE SILENCING; GENETIC MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; UPREGULATION;

CERAMIDE-1-PHOSPHATE; CYTOSOLIC PHOSPHOLIPASE A2; EICOSANOIDS; INFLAMMATION;

ANIMALS; CELLS, CULTURED; CERAMIDES; DISEASE MODELS, ANIMAL; EICOSANOIDS; FEMALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PREGNANCY; PREGNANCY, ANIMAL;

EID: 84878969813     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M035683     Document Type: Article

References (57)

1. Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature. 420: 860-867. (Pubitemid 36019639)
2. Grivennikov, S. I., F. R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell. 140: 883-899.
3. Wang, Z., and T. Nakayama. 2010. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010: 535918.
4. Black, P. H., and L. D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 52: 1-23. (Pubitemid 34130239)
5. Choy, E. H., and G. S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344: 907-916. (Pubitemid 32224400)
6. Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115: 1111-1119. (Pubitemid 40629025)
7. Dandona, P., A. Aljada, and A. Bandyopadhyay. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25: 4-7. (Pubitemid 38032801)
8. Yang, M., R. K. Kumar, P. M. Hansbro, and P. S. Foster. 2012. Emerging roles of pulmonary macrophages in driving the development of severe asthma. J. Leukoc. Biol. 91: 557-569.
9. Woodruff, P. G., B. Modrek, D. F. Choy, G. Jia, A. R. Abbas, A. Ellwanger, L. L. Koth, J. R. Arron, and J. V. Fahy. 2009. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180: 388-395.
10. Leslie, C. C. 1997. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272: 16709-16712.
11. Kramer, R. M., and J. D. Sharp. 1997. Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410: 49-53. (Pubitemid 27283382)
12. Nalefski, E. A., L. A. Sultzman, D. M. Martin, R. W. Kriz, P. S. Towler, J. L. Knopf, and J. D. Clark. 1994. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J. Biol. Chem. 269: 18239-18249.
13. Sharp, J. D., R. T. Pickard, X. G. Chiou, J. V. Manetta, S. Kovacevic, J. R. Miller, A. D. Varshavsky, E. F. Roberts, B. A. Strifler, D. N. Brems, et al. 1994. Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2. J. Biol. Chem. 269: 23250-23254. (Pubitemid 24283313)
14. Huang, Z., P. Payette, K. Abdullah, W. A. Cromlish, and B. P. Kennedy. 1996. Functional identification of the active site nucleophile of the human 85-kDa cytosolic phospholipase A2. Biochemistry. 35: 3712-3721.
15. Lamour, N. F., P. Subramanian, D. S. Wijesinghe, R. V. Stahelin, J. V. Bonventre, and C. E. Chalfant. 2009. Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis. J. Biol. Chem. 284: 26897-26907.
16. Subramanian, P., M. Vora, L. B. Gentile, R. V. Stahelin, and C. E. Chalfant. 2007. Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms. J. Lipid Res. 48: 2701-2708. (Pubitemid 350272855)
17. Lamour, N. F., R. V. Stahelin, D. S. Wijesinghe, M. Maceyka, E. Wang, J. C. Allegood, A. H. Merrill, Jr., W. Cho, and C. E. Chalfant. 2007. Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis. J. Lipid Res. 48: 1293-1304.
18. Subramanian, P., R. V. Stahelin, Z. Szulc, A. Bielawska, W. Cho, and C. E. Chalfant. 2005. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. J. Biol. Chem. 280: 17601-17607. (Pubitemid 41388994)
19. Stahelin, R. V., P. Subramanian, M. Vora, W. Cho, and C. E. Chalfant. 2007. Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain. J. Biol. Chem. 282: 20467-20474. (Pubitemid 47100015)
20. Ward, K. E., N. Bhardwaj, M. Vora, C. E. Chalfant, H. Lu, and R. V. Stahelin. 2013. The molecular basis of ceramide-1-phosphate recognition by C2 domains. J. Lipid Res. 54: 636-648.
21. Wijesinghe, D. S., J. C. Allegood, L. B. Gentile, T. E. Fox, M. Kester, and C. E. Chalfant. 2010. Use of high performance liquid chromatography- electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels. J. Lipid Res. 51: 641-651.
22. Pettus, B. J., A. Bielawska, S. Spiegel, P. Roddy, Y. A. Hannun, and C. E. Chalfant. 2003. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J. Biol. Chem. 278: 38206-38213. (Pubitemid 37221709)
23. Graf, C., B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Müller, E. Fischer, C. Reichel, et al. 2008. Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice. J. Immunol. 180: 3457-3466.
24. Niwa, S., N. Urtz, T. Baumruker, A. Billich, and F. Bornancin. 2010. Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice. Lipids Health Dis. 9: 1.
25. Mitsutake, S., U. Yokose, M. Kato, I. Matsuoka, J. M. Yoo, T. J. Kim, H. S. Yoo, K. Fujimoto, Y. Ando, M. Sugiura, et al. 2007. The generation and behavorial analysis of ceramide kinase-null mice, indicating a function in cerebellar Purkinje cells. Biochem. Biophys. Res. Commun. 363: 519-524. (Pubitemid 47513661)
26. Zhang, Y., L. Zhao, C. Wang, and B. Lei. 2003. Isolation and culture of mouse embryonic fibroblast. Sichuan Da Xue Xue Bao Yi Xue Ban. 34: 344-346. (Pubitemid 37408411)
27. Lamour, N. F., D. S. Wijesinghe, J. A. Mietla, K. E. Ward, R. V. Stahelin, and C. E. Chalfant. 2011. Ceramide kinase regulates the production of tumor necrosis factor a (TNFα) via inhibition of TNFα-converting enzyme. J. Biol. Chem. 286: 42808-42817.
28. Yin, C., L. Xi, X. Wang, M. Eapen, and R. C. Kukreja. 2005. Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice. J. Mol. Cell. Cardiol. 39: 681-689. (Pubitemid 41331056)
29. Natarajan, R., F. N. Salloum, B. J. Fisher, R. C. Kukreja, and A. A. Fowler 3rd. 2006. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ. Res. 98: 133-140. (Pubitemid 43970213)
30. Natarajan, R., F. N. Salloum, B. J. Fisher, L. Smithson, J. Almenara, and A. A. Fowler 3rd. 2009. Prolyl hydroxylase inhibition attenuates post-ischemic cardiac injury via induction of endoplasmic reticulum stress genes. Vascul. Pharmacol. 51: 110-118.
31. Blaho, V. A., M. W. Buczynski, C. R. Brown, and E. A. Dennis. 2009. Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J. Biol. Chem. 284: 21599-21612.
32. Norton, S. K., D. S. Wijesinghe, A. Dellinger, J. Sturgill, Z. Zhou, S. Barbour, C. Chalfant, D. H. Conrad, and C. L. Kepley. 2012. Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma. J. Allergy Clin. Immunol. 130: 761-769.
33. Pettus, B. J., A. Bielawska, P. Subramanian, D. S. Wijesinghe, M. Maceyka, C. C. Leslie, J. H. Evans, J. Freiberg, P. Roddy, Y. A. Hannun, et al. 2004. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279: 11320-11326. (Pubitemid 38401629)
34. Pettus, B. J., K. Kitatani, C. E. Chalfant, T. A. Taha, T. Kawamori, J. Bielawski, L. M. Obeid, and Y. A. Hannun. 2005. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol. 68: 330-335. (Pubitemid 41058296)
35. Wijesinghe, D. S., P. Subramanian, N. F. Lamour, L. B. Gentile, M. H. Granado, A. Bielawska, Z. Szulc, A. Gomez-Munoz, and C. E. Chalfant. 2009. Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipidspecifi c effects. J. Lipid Res. 50: 1986-1995.
36. Boath, A., C. Graf, E. Lidome, T. Ullrich, P. Nussbaumer, and F. Bornancin. 2008. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. J. Biol. Chem. 283: 8517-8526.
37. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, et al. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390: 618-622. (Pubitemid 28016197)
38. Bonventre, J. V., Z. Huang, M. R. Taheri, E. O'Leary, E. Li, M. A. Moskowitz, and A. Sapirstein. 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390: 622-625.
39. Klivenyi, P., M. F. Beal, R. J. Ferrante, O. A. Andreassen, M. Wermer, M. R. Chin, and J. V. Bonventre. 1998. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J. Neurochem. 71: 2634-2637.
40. Bonventre, J. V. 1999. The 85-kD cytosolic phospholipase A2 knockout mouse: a new tool for physiology and cell biology. J. Am. Soc. Nephrol. 10: 404-412.
41. Fujishima, H., R. O. Sanchez Mejia, C. O. Bingham 3rd, B. K. Lam, A. Sapirstein, J. V. Bonventre, K. F. Austen, and J. P. Arm. 1999. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. USA. 96: 4803-4807.
42. Nakatani, N., N. Uozumi, K. Kume, M. Murakami, I. Kudo, and T. Shimizu. 2000. Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells. Biochem. J. 352: 311-317.
43. Nagase, T., N. Uozumi, S. Ishii, K. Kume, T. Izumi, Y. Ouchi, and T. Shimizu. 2000. Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat. Immunol. 1: 42-46.
44. Hong, K. H., J. C. Bonventre, E. O'Leary, J. V. Bonventre, and E. S. Lander. 2001. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc. Natl. Acad. Sci. USA. 98: 3935-3939.
45. Nagase, T., N. Uozumi, S. Ishii, Y. Kita, H. Yamamoto, E. Ohga, Y. Ouchi, and T. Shimizu. 2002. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fi brosis. Nat. Med. 8: 480-484.
46. Haq, S., H. Kilter, A. Michael, J. Tao, E. O'Leary, X. M. Sun, B. Walters, K. Bhattacharya, X. Chen, L. Cui, et al. 2003. Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat. Med. 9: 944-951.
47. Hegen, M., L. Sun, N. Uozumi, K. Kume, M. E. Goad, C. L. Nickerson-Nutter, T. Shimizu, and J. D. Clark. 2003. Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J. Exp. Med. 197: 1297-1302.
48. Miyaura, C., M. Inada, C. Matsumoto, T. Ohshiba, N. Uozumi, T. Shimizu, and A. Ito. 2003. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with infl ammation. J. Exp. Med. 197: 1303-1310.
49. Graf, C., M. Klumpp, M. Habig, P. Rovina, A. Billich, T. Baumruker, B. Oberhauser, and F. Bornancin. 2008. Targeting ceramide metabolism with a potent and specifi c ceramide kinase inhibitor. Mol. Pharmacol. 74: 925-932.
50. Kishimoto, A., Y. Takai, T. Mori, U. Kikkawa, and Y. Nishizuka. 1980. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J. Biol. Chem. 255: 2273-2276.
51. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 308: 693-698.
52. Castagna, M., Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa, and Y. Nishizuka. 1982. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257: 7847-7851.
53. Bonventre, J. V., and M. Swidler. 1988. Calcium dependency of prostaglandin E2 production in rat glomerular mesangial cells. Evidence that protein kinase C modulates the Ca2+-dependent activation of phospholipase A2. J. Clin. Invest. 82: 168-176.
54. Gijón, M. A., D. M. Spencer, A. R. Siddiqi, J. V. Bonventre, and C. C. Leslie. 2000. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J. Biol. Chem. 275: 20146-20156.
55. Dana, R., T. L. Leto, H. L. Malech, and R. Levy. 1998. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J. Biol. Chem. 273: 441-445.
56. Kim, J. H., B. D. Lee, Y. Kim, S. D. Lee, P. G. Suh, and S. H. Ryu. 1999. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines. J. Immunol. 163: 5462-5470.
57. Sugiura, M., K. Kono, H. Liu, T. Shimizugawa, H. Minekura, S. Spiegel, and T. Kohama. 2002. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J. Biol. Chem. 277: 23294-23300.